Discussion stirs around MINDBODY, Inc. (NASDAQ:MB) this week; here is what analysts are saying.

June 16, 2018 - By Peter Erickson

MINDBODY, Inc. (NASDAQ:MB) Logo

MINDBODY, Inc. (NASDAQ:MB) Ratings Coverage

Among 9 analysts covering MINDBODY (NASDAQ:MB), 6 have Buy rating, 0 Sell and 3 Hold. Therefore 67% are positive. MINDBODY had 16 analyst reports since January 8, 2018 according to SRatingsIntel. The stock of MINDBODY, Inc. (NASDAQ:MB) has “Outperform” rating given on Friday, February 23 by Imperial Capital. The stock of MINDBODY, Inc. (NASDAQ:MB) earned “Buy” rating by Jefferies on Monday, January 8. The company was maintained on Thursday, February 22 by Craig Hallum. Credit Suisse downgraded the stock to “Neutral” rating in Wednesday, May 9 report. Craig Hallum downgraded the stock to “Hold” rating in Wednesday, May 9 report. The stock has “Buy” rating by Roth Capital on Wednesday, February 14. Jefferies maintained the shares of MB in report on Monday, April 16 with “Buy” rating. The firm has “Buy” rating given on Tuesday, March 13 by Craig Hallum. The firm has “Outperform” rating by Credit Suisse given on Thursday, February 22. Morgan Stanley maintained the shares of MB in report on Tuesday, January 30 with “Equal-Weight” rating. Below is a list of MINDBODY, Inc. (NASDAQ:MB) latest ratings and price target changes.

09/05/2018 Broker: Craig Hallum Old Rating: Buy New Rating: Hold Old Target: $28 Downgrade
09/05/2018 Broker: Morgan Stanley Old Rating: Equal-Weight New Rating: Equal-Weight Old Target: $39 New Target: $42 Maintain
09/05/2018 Broker: Credit Suisse Old Rating: Outperform New Rating: Neutral Old Target: $36 Downgrade
16/04/2018 Broker: Jefferies Rating: Buy New Target: $45.0000 Maintain
15/03/2018 Broker: Roth Capital Rating: Buy New Target: $46.0 Maintain
14/03/2018 Broker: DA Davidson Rating: Buy New Target: $46.0
13/03/2018 Broker: Craig Hallum Rating: Buy New Target: $45.0 Maintain
13/03/2018 Broker: KeyBanc Capital Markets Old Rating: Overweight New Rating: Overweight Old Target: $41 New Target: $47 Maintain
23/02/2018 Broker: Imperial Capital Old Rating: Outperform New Rating: Outperform Old Target: $35 New Target: $42 Maintain
22/02/2018 Broker: Craig Hallum Rating: Buy New Target: $40.0 Maintain

The stock decreased 3.18% or $1.3 during the last trading session, reaching $39.55. About 479,141 shares traded. MINDBODY, Inc. (NASDAQ:MB) has risen 35.54% since June 16, 2017 and is uptrending. It has outperformed by 22.97% the S&P500.

MINDBODY, Inc. operates a cloud-based business management software and payments platform for the small and medium-sized businesses in the wellness services industry. The company has market cap of $1.88 billion. The Company’s platform enables businesses to run, market, and build client scheduling and online booking, staff management, client relationship management, integrated payment processing, retail point-of-sale, analytics and reporting, simple and intuitive user experience, mobility, branded Web, social integration, cloud architecture, open platform for third-party application development, security and compliance, and integration with other cloud partners for yoga, Pilates, barre, indoor cycling, personal training, martial arts, and dance exercise, spas, salons, music instruction studios, dance studios, childrenÂ’s activity centers, and integrative health centers. It currently has negative earnings. The firm offers its software platform to its subscribers as a subscription service.

More recent MINDBODY, Inc. (NASDAQ:MB) news were published by: Fool.com which released: “1 Top Small-Cap Stock to Buy in June” on June 14, 2018. Also Globenewswire.com published the news titled: “MINDBODY Announces Proposed Private Offering of $200 Million of Convertible Senior Notes” on June 06, 2018. Nasdaq.com‘s news article titled: “MINDBODY Announces Pricing of Upsized $270 Million Convertible Senior Notes Offering” with publication date: June 08, 2018 was also an interesting one.

MINDBODY, Inc. (NASDAQ:MB) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.